{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T03:41:18Z","timestamp":1781581278606,"version":"3.54.5"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:00:00Z","timestamp":1692835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:00:00Z","timestamp":1692835200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s40266-023-01058-w","type":"journal-article","created":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T18:02:56Z","timestamp":1692900176000},"page":"1017-1026","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Anticholinergic Burden and Cognitive Impairment in Nursing Homes: A Comparison of Four Anticholinergic Scales"],"prefix":"10.1007","volume":"40","author":[{"given":"Alessio","family":"Novella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Elli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aladar","family":"Ianes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4777-1350","authenticated-orcid":false,"given":"Luca","family":"Pasina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,24]]},"reference":[{"key":"1058_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/bcpt.12140","volume":"114","author":"H Kersten","year":"2014","unstructured":"Kersten H, Wyller TB. Anticholinergic drug burden in older people\u2019s brain\u2014how well is it measured? Basic Clin Pharmacol Toxicol. 2014;114:151\u20139.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"1058_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12877-015-0029-9","volume":"15","author":"MS Salahudeen","year":"2015","unstructured":"Salahudeen MS, Duffull SB, Nishtala PS. Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review. BMC Geriatr. 2015;15:31.","journal-title":"BMC Geriatr"},{"key":"1058_CR3","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s40266-015-0310-9","volume":"32","author":"K Cardwell","year":"2015","unstructured":"Cardwell K, Hughes CM, Ryan C. The association between anticholinergic medication burden and health related outcomes in the \u201coldest old\u201d: a systematic review of the literature. Drugs Aging. 2015;32:835\u201348.","journal-title":"Drugs Aging"},{"key":"1058_CR4","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s40266-018-0549-z","volume":"35","author":"TJ Welsh","year":"2018","unstructured":"Welsh TJ, van der Wardt V, Ojo G, Gordon AL, Gladman JRF. Anticholinergic drug burden tools\/scales and adverse outcomes in different clinical settings: a systematic review of reviews. Drugs Aging. 2018;35:523\u201338.","journal-title":"Drugs Aging"},{"key":"1058_CR5","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1093\/ageing\/afu096","volume":"43","author":"C Fox","year":"2014","unstructured":"Fox C, Smith T, Maidment I, Chan W-Y, Bua N, Myint PK, et al. Effect of medications with anti-cholinergic properties on cognitive function, delirium, physical function and mortality: a systematic review. Age Ageing. 2014;43:604\u201315.","journal-title":"Age Ageing"},{"key":"1058_CR6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jamda.2020.04.019","volume":"22","author":"A Egberts","year":"2021","unstructured":"Egberts A, Moreno-Gonzalez R, Alan H, Ziere G, Mattace-Raso FUS. Anticholinergic drug burden and delirium: a systematic review. J Am Med Dir Assoc. 2021;22:65-73.e4.","journal-title":"J Am Med Dir Assoc"},{"key":"1058_CR7","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/sj.bjp.0706780","volume":"148","author":"P Abrams","year":"2006","unstructured":"Abrams P, Andersson K-E, Buccafusco JJ, Chapple C, de Groat WC, Fryer AD, et al. Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder. Br J Pharmacol. 2006;148:565\u201378.","journal-title":"Br J Pharmacol"},{"key":"1058_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151084","volume":"11","author":"MS Salahudeen","year":"2016","unstructured":"Salahudeen MS, Chyou T-Y, Nishtala PS. Serum anticholinergic activity and cognitive and functional adverse outcomes in older people: a systematic review and meta-analysis of the literature. PLoS ONE. 2016;11: e0151084.","journal-title":"PLoS ONE"},{"key":"1058_CR9","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00228-020-02994-x","volume":"77","author":"A Lisibach","year":"2021","unstructured":"Lisibach A, Benelli V, Ceppi MG, Waldner-Knogler K, Csajka C, Lutters M. Quality of anticholinergic burden scales and their impact on clinical outcomes: a systematic review. Eur J Clin Pharmacol. 2021;77:147\u201362.","journal-title":"Eur J Clin Pharmacol"},{"key":"1058_CR10","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1007\/s40266-018-0584-9","volume":"35","author":"G Brombo","year":"2018","unstructured":"Brombo G, Bianchi L, Maietti E, Malacarne F, Corsonello A, Cherubini A, et al. Association of anticholinergic drug burden with cognitive and functional decline over time in older inpatients: results from the CRIME Project. Drugs Aging. 2018;35:917\u201324.","journal-title":"Drugs Aging"},{"key":"1058_CR11","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1007\/s00228-013-1499-3","volume":"69","author":"CE Dur\u00e1n","year":"2013","unstructured":"Dur\u00e1n CE, Azermai M, Vander Stichele RH. Systematic review of anticholinergic risk scales in older adults. Eur J Clin Pharmacol. 2013;69:1485\u201396.","journal-title":"Eur J Clin Pharmacol"},{"key":"1058_CR12","doi-asserted-by":"publisher","first-page":"195","DOI":"10.7326\/0003-4819-123-3-199508010-00007","volume":"123","author":"J Avorn","year":"1995","unstructured":"Avorn J, Gurwitz JH. Drug use in the nursing home. Ann Intern Med. 1995;123:195\u2013204.","journal-title":"Ann Intern Med"},{"key":"1058_CR13","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s00228-020-02871-7","volume":"76","author":"L Pasina","year":"2020","unstructured":"Pasina L, Novella A, Cortesi L, Nobili A, Tettamanti M, Ianes A. Drug prescriptions in nursing home residents: an Italian multicenter observational study. Eur J Clin Pharmacol. 2020;76:1011\u20139.","journal-title":"Eur J Clin Pharmacol"},{"key":"1058_CR14","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.jamda.2014.08.002","volume":"15","author":"F Landi","year":"2014","unstructured":"Landi F, Dell\u2019Aquila G, Collamati A, Martone AM, Zuliani G, Gasperini B, et al. Anticholinergic drug use and negative outcomes among the frail elderly population living in a nursing home. J Am Med Dir Assoc. 2014;15:825\u20139.","journal-title":"J Am Med Dir Assoc"},{"key":"1058_CR15","doi-asserted-by":"publisher","first-page":"311","DOI":"10.2217\/1745509X.4.3.311","volume":"4","author":"M Boustani","year":"2008","unstructured":"Boustani M, Campbell N, Munger S, Maidment I, Fox C. Impact of anticholinergics on the aging brain: a review and practical application. Aging Health. 2008;4:311\u201320.","journal-title":"Aging Health"},{"key":"1058_CR16","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1001\/archinternmed.2007.106","volume":"168","author":"JL Rudolph","year":"2008","unstructured":"Rudolph JL, Salow MJ, Angelini MC, McGlinchey RE. The anticholinergic risk scale and anticholinergic adverse effects in older persons. Arch Intern Med. 2008;168:508\u201313.","journal-title":"Arch Intern Med"},{"key":"1058_CR17","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12877-018-0929-6","volume":"18","author":"EK Kiesel","year":"2018","unstructured":"Kiesel EK, Hopf YM, Drey M. An anticholinergic burden score for German prescribers: score development. BMC Geriatr. 2018;18:239.","journal-title":"BMC Geriatr"},{"key":"1058_CR18","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3390\/jpm12020207","volume":"12","author":"H Ramos","year":"2022","unstructured":"Ramos H, Moreno L, P\u00e9rez-Tur J, Ch\u00e1fer-Peric\u00e1s C, Garc\u00eda-Lluch G, Pardo J. CRIDECO Anticholinergic load scale: an updated anticholinergic burden scale. Comparison with the ACB scale in spanish individuals with subjective memory complaints. J Pers Med. 2022;12:207.","journal-title":"J Pers Med."},{"key":"1058_CR19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s40266-018-0516-8","volume":"35","author":"N Masnoon","year":"2018","unstructured":"Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. Tools for assessment of the appropriateness of prescribing and association with patient-related outcomes: a systematic review. Drugs Aging. 2018;35:43\u201360.","journal-title":"Drugs Aging"},{"key":"1058_CR20","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s40266-013-0109-5","volume":"30","author":"S Ghibelli","year":"2013","unstructured":"Ghibelli S, Marengoni A, Djade CD, Nobili A, Tettamanti M, Franchi C, et al. Prevention of inappropriate prescribing in hospitalized older patients using a computerized prescription support system (INTERcheck\u00ae). Drugs Aging. 2013;30:821\u20138.","journal-title":"Drugs Aging"},{"key":"1058_CR21","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s40266-015-0336-z","volume":"33","author":"L Pasina","year":"2016","unstructured":"Pasina L, Marengoni A, Ghibelli S, Suardi F, Djade CD, Nobili A, et al. A multicomponent intervention to optimize psychotropic drug prescription in elderly nursing home residents: an Italian multicenter, prospective, pilot study. Drugs Aging. 2016;33:143\u20139.","journal-title":"Drugs Aging"},{"key":"1058_CR22","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1212\/WNL.43.12.2457","volume":"43","author":"JC Morris","year":"1993","unstructured":"Morris JC, Edland S, Clark C, Galasko D, Koss E, Mohs R, et al. The consortium to establish a registry for Alzheimer\u2019s disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer\u2019s disease. Neurology. 1993;43:2457\u201365.","journal-title":"Neurology"},{"key":"1058_CR23","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1080\/02813432.2016.1207142","volume":"34","author":"M Teramura-Gr\u00f6nblad","year":"2016","unstructured":"Teramura-Gr\u00f6nblad M, Raivio M, Savikko N, Muurinen S, Soini H, Suominen M, et al. Potentially severe drug-drug interactions among older people and associations in assisted living facilities in Finland: a cross-sectional study. Scand J Prim Health Care. 2016;34:250\u20137.","journal-title":"Scand J Prim Health Care"},{"key":"1058_CR24","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1370\/afm.2131","volume":"15","author":"W-H Hsu","year":"2017","unstructured":"Hsu W-H, Wen Y-W, Chen L-K, Hsiao F-Y. Comparative associations between measures of anti-cholinergic burden and adverse clinical outcomes. Ann Fam Med. 2017;15:561\u20139.","journal-title":"Ann Fam Med"},{"key":"1058_CR25","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s00228-019-02795-x","volume":"76","author":"S Ali","year":"2020","unstructured":"Ali S, Peterson GM, Bereznicki LR, Salahudeen MS. Association between anticholinergic drug burden and mortality in older people: a systematic review. Eur J Clin Pharmacol. 2020;76:319\u201335.","journal-title":"Eur J Clin Pharmacol"},{"key":"1058_CR26","unstructured":"Patnode CD, Perdue LA, Rossom RC, Rushkin MC, Redmond N, Thomas RG, et al. Screening for cognitive impairment in older adults: an evidence update for the U.S. Preventive Services Task Force [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2020 [cited 2023 Jun 7]. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK554654\/. Accessed 23 Aug 2023."},{"key":"1058_CR27","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1111\/j.1532-5415.2011.03491.x","volume":"59","author":"C Fox","year":"2011","unstructured":"Fox C, Richardson K, Maidment ID, Savva GM, Matthews FE, Smithard D, et al. Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study. J Am Geriatr Soc. 2011;59:1477\u201383.","journal-title":"J Am Geriatr Soc"},{"key":"1058_CR28","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1002\/pds.5159","volume":"29","author":"L Pasina","year":"2020","unstructured":"Pasina L, Lucca U, Tettamanti M. Relation between anticholinergic burden and cognitive impairment: results from the Monzino 80-plus population-based study. Pharmacoepidemiol Drug Saf. 2020;29:1696\u2013702.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1058_CR29","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s40266-018-0612-9","volume":"36","author":"L Pasina","year":"2019","unstructured":"Pasina L, Colzani L, Cortesi L, Tettamanti M, Zambon A, Nobili A, et al. Relation between delirium and anticholinergic drug burden in a cohort of hospitalized older patients: an observational study. Drugs Aging. 2019;36:85\u201391.","journal-title":"Drugs Aging"},{"key":"1058_CR30","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s40266-012-0044-x","volume":"30","author":"L Pasina","year":"2013","unstructured":"Pasina L, Djade CD, Lucca U, Nobili A, Tettamanti M, Franchi C, et al. Association of anticholinergic burden with cognitive and functional status in a cohort of hospitalized elderly: comparison of the anticholinergic cognitive burden scale and anticholinergic risk scale: results from the REPOSI study. Drugs Aging. 2013;30:103\u201312.","journal-title":"Drugs Aging"},{"key":"1058_CR31","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1007\/s00228-021-03125-w","volume":"77","author":"L Pasina","year":"2021","unstructured":"Pasina L, Rizzi B, Nobili A, Recchia A. Anticholinergic load and delirium in end-of-life patients. Eur J Clin Pharmacol. 2021;77:1419\u201324.","journal-title":"Eur J Clin Pharmacol"},{"key":"1058_CR32","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jamda.2018.10.026","volume":"20","author":"C-H Kua","year":"2019","unstructured":"Kua C-H, Mak VSL, Huey Lee SW. Health outcomes of deprescribing interventions among older residents in nursing homes: a systematic review and meta-analysis. J Am Med Dir Assoc. 2019;20:362-372.e11.","journal-title":"J Am Med Dir Assoc"},{"key":"1058_CR33","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s11096-019-00784-9","volume":"41","author":"N Ailabouni","year":"2019","unstructured":"Ailabouni N, Mangin D, Nishtala PS. DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilities. Int J Clin Pharm. 2019;41:167\u201378.","journal-title":"Int J Clin Pharm"},{"key":"1058_CR34","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1001\/archinte.167.8.781","volume":"167","author":"SN Hilmer","year":"2007","unstructured":"Hilmer SN, Mager DE, Simonsick EM, Cao Y, Ling SM, Windham BG, et al. A drug burden index to define the functional burden of medications in older people. Arch Intern Med. 2007;167:781\u20137.","journal-title":"Arch Intern Med"},{"key":"1058_CR35","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1080\/17512433.2018.1528145","volume":"11","author":"SN Hilmer","year":"2018","unstructured":"Hilmer SN. Calculating and using the drug burden index score in research and practice. Expert Rev Clin Pharmacol. 2018;11:1053\u20135.","journal-title":"Expert Rev Clin Pharmacol"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-023-01058-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-023-01058-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-023-01058-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T10:19:30Z","timestamp":1698229170000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-023-01058-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,24]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["1058"],"URL":"https:\/\/doi.org\/10.1007\/s40266-023-01058-w","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,24]]},"assertion":[{"value":"27 July 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No sources of funding were used in the conducting of this study or the preparation of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors have no conflicts of interest that are directly relevant to the content of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"Data collection complied fully with Italian law on personal data protection, and the study was approved by the ethics committee of the IRCCS Carlo Besta Foundation.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"All data were anonymous, and informed consent was not required for the purpose of this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The data are not publicly available due to privacy or ethical restrictions. Data will be made available on request.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Availability Statement"}},{"value":"The code that supports the findings of this study is available on request from the corresponding author.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"All authors participated in drafting the manuscript or critical revision of the manuscript for important intellectual content and provided approval of the final submitted version. Individual contributions are as follows: LP and AN designed the study, interpreted data, and wrote the manuscript; CE carried out and interpreted statistical analyses; AI made the final critical revision for important intellectual content.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 Individual Contributions"}}]}}